- 全部删除
您的购物车当前为空
GSK251是一种新型的,口服生物利用度高的PI3Kδ抑制剂,具有高效性和高选择性,且具有独特的结合模式。


为众多的药物研发团队赋能,
让新药发现更简单!
GSK251是一种新型的,口服生物利用度高的PI3Kδ抑制剂,具有高效性和高选择性,且具有独特的结合模式。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,660 | In stock | |
| 5 mg | ¥ 3,950 | In stock | |
| 10 mg | ¥ 5,290 | In stock | |
| 25 mg | ¥ 7,980 | In stock | |
| 50 mg | ¥ 10,600 | In stock | |
| 100 mg | ¥ 14,500 | In stock |
GSK251 相关产品
| 产品描述 | GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode. |
| 分子量 | 584.71 |
| 分子式 | C29H37FN6O4S |
| CAS No. | 2125968-05-8 |
| Smiles | COc1ncc(cc1S(=O)(=O)Nc1ccnc(c1)-c1ccc(CN2CCN(CC2)C(C)C)cc1F)N1CCOCC1 |
| 密度 | 1.295 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (85.5 mM), Sonication and heating to 60℃ are recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.42 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容